AASLD 2024: Daniel Lim's Entry #834857

Entry #: 834857 by Daniel Lim

Your correct picks are shown in green and your incorrect picks are shown in red.

Round 1 

HepComm: Living with Cirrhosis 

LT: Pushing the limits in HCC 

HepComm: Machine Age 

LT: Rise of the Machines 

HepComm: Uncovering Alcohol 

LT: Post Transplant Complications 

HepComm: FinTox 

LT: Disparities in Liver Transplant 

HepComm: Statins! 

LT: Before and After 

HepComm: Bridging Gaps 

LT: Living donation and splits 

HepComm: Beyond BMI 

LT: Liver Allocation  

HepComm: Immunotherapy for HCC 

LT: The Liver and the Kidney 

Round 2 

LT: Pushing the limits in HCC

HepComm: Machine Age

HepComm: Uncovering Alcohol

HepComm: FinTox

HepComm: Statins!

LT: Living donation and splits

HepComm: Beyond BMI

HepComm: Immunotherapy for HCC

Round 3 

HepComm: Machine Age

HepComm: FinTox

HepComm: Statins!

HepComm: Immunotherapy for HCC

Round 4 

HepComm: Machine Age

HepComm: Immunotherapy for HCC

Champion 

HepComm: Machine Age